ask="N/A"
ask_size="N/A"
average_daily_volume="112524"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="-0.01"
change_from_200_day_moving_average="-0.34"
change_from_50_day_moving_average="-0.08"
change_from_52_week_high="-1.64"
change_From_52_week_low="0.21"
change_in_percent="-0.63%"
close="1.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.36"
ebitda="-8.60M"
eps_estimate_current_year="-0.31"
eps_estimate_next_quarter="-0.06"
eps_estimate_next_year="-0.33"
ex_dividend_date="N/A"
float_shares="13184000"
high="2.10"
high_52_weeks="3.59"
last_trade_date="2/28/2017"
last_trade_price="1.95"
last_trade_size="400"
last_trade_time="4:02pm"
low="1.91"
low_52_weeks="1.74"
market_capitalization="26.09M"
moving_average_200_day="2.29"
moving_average_50_day="2.03"
name="Can-Fite Biopharma Ltd Sponsore"
notes="N/A"
one_year_target_price="5.00"
open="2.09"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-14.70%"
percent_change_from_50_day_moving_average="-3.86%"
percent_change_from_52_week_high="-45.68%"
percent_change_from_52_week_low="+12.07%"
previous_close="1.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.42"
price_per_sales="130.38"
revenue="201373.00"
shares_outstanding="13379000"
short_ratio="1.11"
stock_exchange="ASE"
symbol="CANF"
volume="205414"
weeks_range_52="1.74 - 3.59"
